Human LILRB2/CD85d/ILT4 Protein (LIL-HM3B2)
Catalog: LIL-HM3B2
Order now get it on
Product Description | Recombinant Human LILRB2/CD85d/ILT4 Protein is expressed from HEK293 with mFc (IgG1) tag at the C-Terminus.It contains Gln22-His458. |
Product Category | Recombinant Protein |
Target | LILRB2/CD85d/ILT4 |
Synonyms | CD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10 |
Gene/Protein ID | Q8N423-1 |
Species | Human |
Exact Sequence | Gln22-His458 |
Molecular Weight | The protein has a predicted MW of 73.6 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result. |
Activity | Immobilized Human LILRB2, mFc Tag at 0.2ug/ml (100ul/well) on the plate. Dose response curve for Anti-LILRB2 Antibody, hFc Tag with the EC50 of 10.2ng/ml determined by ELISA (QC Test). See testing image for detail. |
Product Tag | C-mFc |
Express System | HEK293 |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Endotoxin | Less than 1EU per ug by the LAL method. |
Form | Lyophilized |
Shipping | Shipped at ambient temperature. |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Stability And Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
You may also be interested in
View more associated products